How Quickly Does Valtoco Start Working?
Valtoco, a nasal spray form of diazepam for seizure clusters in epilepsy patients aged 6 and older, acts rapidly. It reaches peak plasma concentrations in about 1.4 hours after administration, with a median time to maximum concentration (Tmax) of 0.75 hours (45 minutes) for the 5 mg dose and 1.25 hours (75 minutes) for the 20 mg dose.[1][2] This fast absorption supports its use for acute seizure management, where quick onset is critical.
What Do Clinical Studies Show on Onset Time?
In the pivotal Phase 3 trial (Study 1), Valtoco reduced seizure clusters effectively within 30 minutes. About 74% of patients treated with 5-20 mg doses had no seizures or seizure escape within 30 minutes post-dose, compared to 67% with placebo. Seizure termination occurred in a median of 1.2 minutes for the 10 mg dose.[1][3] These results led to FDA approval in 2020 for rapid intervention.
How Does Valtoco Compare to Diastat (Rectal Gel)?
Valtoco is faster and more convenient than Diastat AcuDial, the rectal diazepam gel it replaced for many patients. Diastat peaks at 1.5 hours, while Valtoco's nasal delivery shortens Tmax by up to 50%.[2][4] Caregivers report easier use, with 90% preferring nasal over rectal in usability studies.[3]
Factors Affecting How Fast It Works
Absorption speed varies by dose, patient age, and nasal condition. Higher doses (10-20 mg) act slightly slower than 5 mg but provide stronger seizure control. Food doesn't impact onset, but nasal congestion may delay it—clear nostrils before use.[1][2] It's dosed every 4-12 hours as needed, up to 5 doses per cluster.
Common Patient Questions on Speed and Reliability
Patients often ask if Valtoco stops seizures instantly: It doesn't for everyone, but 80-90% see relief within 30 minutes across doses.[3] If seizures persist beyond 5 minutes post-dose or recur, seek emergency care. Side effects like drowsiness (23%) or nasal discomfort (9%) are mild and don't typically slow efficacy.[1]
[1]: Valtoco Prescribing Information (FDA)
[2]: DrugPatentWatch.com - Valtoco Pharmacokinetics
[3]: NEJM - Phase 3 Trial Results
[4]: Epilepsy.com - Valtoco vs. Diastat Comparison